L-NAME Hydrochloride: NOS Inhibition Guide
2026-09-01
L-NAME Hydrochloride, also called NG-nitro-L-arginine methyl ester hydrochloride, is a competitive nitric oxide synthase inhibitor for mechanistic research. The compound supports vascular tone regulation studies, hypertension research, and controlled analysis of nitric oxide and inflammatory signaling.
Stattic Workflow for STAT3 Inhibition Research
2026-08-31
Stattic provides a practical way to test whether STAT3 dimerization, phosphorylation, and nuclear signaling drive a phenotype. This workflow connects HNSCC radiosensitization with a carefully bounded lymphatic endothelial-cell application inspired by recent pathway research.
(S)-Mephenytoin in Intestinal Organoid Assays
2026-08-31
Discover how (S)-Mephenytoin can function as a CYP2C19 substrate probe in human iPSC-derived intestinal organoid workflows. This guide focuses on assay architecture, metabolite interpretation, and the practical limits of translating organoid CYP activity into pharmacokinetic evidence.
Cefepime (BMY-28142) in Viability Assays
2026-08-30
Learn how Cefepime (BMY-28142), SKU BA1013, can be integrated into bacterial infection models without confusing antimicrobial effects with host-cell viability. This scenario-based guide covers assay compatibility, fresh-solution handling, interpretation, and practical product selection.
Ceftolozane/Tazobactam: Innovation and Evidence
2026-08-29
This review evaluates ceftolozane/tazobactam as an antipseudomonal cephalosporin and beta-lactamase inhibitor combination designed to address resistant gram-negative infections. Its key contribution is the integration of mechanism, resistance activity, pharmacokinetics, pharmacodynamics, clinical trial evidence, and safety data into a framework for interpreting its use in complicated intraabdominal and urinary tract infections.
Sodium Citrate for Reproducible SERS Assays
2026-08-29
Sodium citrate can provide a controllable chemical environment for SERS assay development, but its effects on plasmonic assembly must be separated from the geometry of the substrate. This article translates a 3D gold nanocluster study into a practical framework for buffer, chelation, protein-matrix, and reproducibility decisions.
THBS1 in Laryngeal Cancer: Evidence and Methods
2026-08-28
The reference study combines transcriptomic cohorts, machine-learning feature selection, immune-pathway analysis, and cell-based assays to identify THBS1 as a prognostic and functionally relevant factor in laryngeal cancer. Its results connect THBS1 with epithelial-to-mesenchymal transition, integrin signaling, lipid metabolism, immune suppression, and a possible clopidogrel-related therapeutic vulnerability, while highlighting the need for clinical validation.
NF 449: Selective Purinergic Receptor Antagonist
2026-08-28
NF 449 is a receptor subtype-selective tool for separating ATP-driven P2X1 signaling from P2Y1 and P2Y12 responses in platelet experiments. This guide translates its receptor pharmacology into practical workflows for platelet activation studies, collagen assays, thrombosis models, and troubleshooting.
AG-126: A Decision Framework for ERK Studies
2026-08-27
AG-126 and Tyrphostin AG-126 provide a focused way to test whether ERK1/2 signaling contributes to inflammation and striatal circuit phenotypes. This article presents an evidence-calibrated assay framework that separates ERK causality from PKC-driven neuronal mechanisms.
HotStart 2X Green qPCR Master Mix: Workflow Guide
2026-08-27
Build reproducible SYBR Green assays for real-time PCR gene expression analysis, RNA-seq validation, and nucleic acid quantification with a streamlined hot-start workflow. The guide translates targeted mRNA nanovaccine findings into practical qPCR readouts while addressing specificity, controls, and melt-curve troubleshooting.
Ertapenem Sodium Salt in Resistance Workflows
2026-08-26
Ertapenem sodium salt supports reproducible MIC, time-kill, and resistance-transfer experiments without forcing researchers to treat phenotype as a substitute for genotype. This workflow-focused guide connects carbapenem exposure assays with plasmid localization, conjugation, PCR, and troubleshooting strategies for antibiotic resistance research.
WAY-100635 in 5-HT1A Assay Workflows
2026-08-26
Use WAY-100635 to separate 5-HT1A receptor signaling from agonist-driven behavioral, pain, and neuronal effects. This guide connects binding assays, functional pharmacology, behavioral controls, and imaging-oriented workflows while highlighting practical troubleshooting.
Sodium Dicloxacillin Monohydrate: Translational Strategy
2026-08-25
A mechanistic and translational guide to using sodium dicloxacillin monohydrate for MSSA research, integrating PBP inhibition, intracellular activity, PK/PD design, pH effects, and drug–drug interaction considerations.
4-Ethylphenyl Sulfate: From Toxin to Translation
2026-08-25
4-Ethylphenyl sulfate is more than a catalog analyte: it offers a translational bridge between microbiota-derived chemistry, renal dysfunction, neurobehavioral phenotypes, and disease-conditioned biomaterial performance. This article outlines how researchers can build rigorous assays around 4-ethylphenyl hydrogen sulfate while avoiding overinterpretation of biomarker and causal evidence.
SIRT1–PGC-1α/TFAM Signaling in Prion Toxicity
2026-08-24
Zhao et al. identify a mechanistic pathway in which reduced SIRT1 activity contributes to PrP106–126-induced mitochondrial injury in N2a neuroblastoma cells. The study shows that SIRT1 enhancement, including resveratrol treatment, supports PGC-1α–TFAM-mediated mitochondrial biogenesis, improves mitochondrial integrity, and reduces apoptosis.
511 records 10/35 page Previous Next First page 上5页 678910 下5页 Last page